HALO CIK: 1159036

Halozyme Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.36
FY22:
0.52
FY23:
0.64
FY24:
0.86
FY25:
1.17
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.28
FY22:
0.27
FY23:
0.34
FY24:
0.55
FY25:
0.47
(positive)
Change from FY21 to FY24
billions USD
FY21:
0.28
FY22:
0.32
FY23:
0.42
FY24:
0.63
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.25
FY22:
0.25
FY23:
0.35
FY24:
0.56
FY25:
0.47
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.40
FY22:
0.20
FY23:
0.28
FY24:
0.44
FY25:
0.32

All amounts in billions USD Data sources:SEC EDGARTwelve Data